Clene Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CLNN research report →
About the company
Clene Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to the discovery, advancement, and market introduction of pioneering therapeutic agents utilizing clean-surfaced nanotechnology (CSN). CNM-Au8 stands as its flagship compound, currently under evaluation across a diverse range of clinical studies.
- CEO
- Robert Etherington
- IPO
- 2018
- Employees
- 75
- HQ
- Salt Lake City, UT, US
Price Chart
- Market Cap
- $62.88M
- P/E
- -1.88
- P/S
- 469.23
- P/B
- -3.78
- EV/EBITDA
- -2.70
- Div Yield
- 0.00%
- Gross Margin
- -182.09%
- Op Margin
- -15535.07%
- Net Margin
- -25009.70%
- ROE
- 233.93%
- ROIC
- -118.10%
- Revenue
- $200.00K · -41.52%
- Net Income
- $-26,173,000 · 33.57%
- EPS
- $-2.65 · 53.26%
- Op Income
- $-23,083,000
- FCF YoY
- 12.91%
- 52W High
- $13.50
- 52W Low
- $3.25
- 50D MA
- $6.26
- 200D MA
- $6.55
- Beta
- 0.92
- Avg Volume
- 499.30K
Get TickerSpark's AI analysis on CLNN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 11, 26 | Mortenson Mark | other | 45,000 |
| Jun 11, 26 | Etherington Robert Dee | other | 65,000 |
| Jun 11, 26 | BROWN MORGAN R | other | 15,000 |
| May 21, 26 | McLaughlin Vallerie | other | 2,064 |
| May 21, 26 | McLaughlin Vallerie | other | 1,500 |
| May 21, 26 | Desai Arjun JJ | other | 2,158 |
| May 21, 26 | Desai Arjun JJ | other | 1,500 |
| May 21, 26 | Mosca Alison | other | 2,861 |
| May 21, 26 | Mosca Alison | other | 1,500 |
| May 21, 26 | MATLIN DAVID J | other | 3,659 |
Our CLNN coverage
Recent articles, reports, and earnings notes.
No research on CLNN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CLNN report →Similar companies
Peers in the same neighborhood.